Literature DB >> 6734709

Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.

B M Frey, H J Schaad, F J Frey.   

Abstract

The oestrogenic component of oral contraceptives affects the activity of liver enzymes and the concentrations of plasma proteins implicated in steroid metabolism and transport. The present study was designed to determine these effects on the kinetics of prednisone and prednisolone. After an oral dose of prednisone, women on oral contraceptive steroids (n = 10) had higher mean (+/- SD) area under the plasma concentration versus time curves of total (428 +/- 67 micrograms/ml/min vs 188 +/- 28 micrograms/ml/min, p less than 0.001) and unbound prednisolone (64 +/- 10 micrograms/ml/min vs 41 +/- 10 micrograms/ml/min, p less than 0.001) than women not taking oral contraceptive steroids (n = 10). The differences were attributable to a lower non-renal clearance of prednisolone and to a higher apparent systemic availability of the drug in contraceptive users than in the controls. The affinity of albumin and transcortin for prednisolone was lower in women on oral contraceptives than in controls (p less than 0.001). Thus, altered kinetics and protein binding may account for the known increase in glucocorticoid efficacy by oestrogens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734709     DOI: 10.1007/BF00542149

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  32 in total

1.  Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study.

Authors:  P M Brooks; W W Buchanan; M Grove; W W Downie
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

2.  Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.

Authors:  S Roy; D R Mishell; G Gray; R Dozono-Takano; P F Brenner; I Eide; V de Quattro; S T Shaw
Journal:  Am J Obstet Gynecol       Date:  1980-04-01       Impact factor: 8.661

3.  Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data.

Authors:  A Somogyi; M Eichelbaum; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Conversion of cortisone to cortisol and prednisone to prednisolone.

Authors:  J S Jenkins; P A Sampson
Journal:  Br Med J       Date:  1967-04-22

5.  Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.

Authors:  F J Frey; B M Frey
Journal:  Am J Kidney Dis       Date:  1984-03       Impact factor: 8.860

6.  Simultaneous measurement of prednisone, prednisolone and 6 beta-hydroxyprednisolone in urine by high-performance liquid chromatography coupled with a radioactivity detector.

Authors:  B M Frey; F J Frey
Journal:  J Chromatogr       Date:  1982-05-14

7.  Prednisolone clearance at steady state in man.

Authors:  U F Legler; F J Frey; L Z Benet
Journal:  J Clin Endocrinol Metab       Date:  1982-10       Impact factor: 5.958

8.  Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism.

Authors:  F J Frey; B M Frey
Journal:  J Lab Clin Med       Date:  1983-04

9.  A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone.

Authors:  F J Frey; F Lozada; T Guentert; B M Frey
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

10.  Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients.

Authors:  J G Gambertoglio; F Vincenti; N J Feduska; J Birnbaum; O Salvatierra; W J Amend
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

View more
  6 in total

Review 1.  Clinical pharmacokinetics of prednisone and prednisolone.

Authors:  B M Frey; F J Frey
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 2.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.

Authors:  Troels K Bergmann; Katherine A Barraclough; Katie J Lee; Christine E Staatz
Journal:  Clin Pharmacokinet       Date:  2012-11       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of contraceptive steroids. An update.

Authors:  G M Shenfield; J M Griffin
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 5.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

6.  [Transcortin concentrations in the plasma of normal persons and patients with kidney and liver diseases].

Authors:  B M Frey; T Hugentobler; M Bührer; F J Frey
Journal:  Klin Wochenschr       Date:  1984-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.